Partial deletion of argininosuccinate synthase protects from pyrazole plus lipopolysaccharide-induced liver injury by decreasing nitrosative stress

被引:5
|
作者
Lu, Yongke [1 ]
Leung, Tung Ming [1 ]
Ward, Stephen C. [2 ]
Nieto, Natalia [1 ]
机构
[1] Mt Sinai Sch Med, Div Liver Dis, Dept Med, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA
关键词
urea cycle; L-citrulline/nitric oxide cycle; nitric oxide synthase-2; NITRIC-OXIDE SYNTHASE; VASCULAR SMOOTH-MUSCLE; NECROSIS-FACTOR-ALPHA; CITRULLINE-NO CYCLE; TYROSINE NITRATION; TREATED RATS; FAS-ANTIBODY; UREA CYCLE; TNF-ALPHA; IN-VIVO;
D O I
10.1152/ajpgi.00375.2011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Lu Y, Leung TM, Ward SC, Nieto N. Partial deletion of argininosuccinate synthase protects from pyrazole plus lipopolysaccharide-induced liver injury by decreasing nitrosative stress. Am J Physiol Gastrointest Liver Physiol 302: G287-G295, 2012. First published November 3, 2011; doi:10.1152/ajpgi.00375.2011.-Argininosuccinate synthase (ASS) is the rate-limiting enzyme in the urea cycle. Along with nitric oxide synthase (NOS)-2, ASS endows cells with the L-citrulline/nitric oxide (NO center dot) salvage pathway to continually supply L-arginine from L-citrulline for sustained NO center dot generation. Because of the relevant role of NOS in liver injury, we hypothesized that downregulation of ASS could decrease the availability of intracellular substrate for NO center dot synthesis by NOS-2 and, hence, decrease liver damage. Previous work demonstrated that pyrazole plus LPS caused significant liver injury involving NO center dot generation and formation of 3-nitrotyrosine protein adducts; thus, wild-type (WT) and Ass(+/-) mice (Ass(+/-) mice are lethal) were treated with pyrazole plus LPS, and markers of nitrosative stress, as well as liver injury, were analyzed. Partial ablation of Ass protected from pyrazole plus LPS-induced liver injury by decreasing nitrosative stress and hepatic and circulating TNF alpha. Moreover, apoptosis was prevented, since pyrazole plus LPS-treated Ass(+/-) mice showed decreased phosphorylation of JNK; increased MAPK phosphatase-1, which is known to deactivate JNK signaling; and lower cleaved caspase-3 than treated WT mice, and this was accompanied by less TdT-mediated dUTP nick end labeling-positive staining. Lastly, hepatic neutrophil accumulation was almost absent in pyrazole plus LPS-treated Ass(+/-) compared with WT mice. Partial Ass ablation prevents pyrazole plus LPS-mediated liver injury by reducing nitrosative stress, TNF alpha, apoptosis, and neutrophil infiltration.
引用
收藏
页码:G287 / G295
页数:9
相关论文
共 50 条
  • [41] CD47 deficiency protects mice from lipopolysaccharide-induced acute lung injury and Escherichia coli pneumonia
    Su, Xiao
    Johansen, Mette
    Looney, Mark R.
    Brown, Eric J.
    Matthay, Michael A.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (10): : 6947 - 6953
  • [42] Geniposide, an Iridoid Glucoside Derived from Gardenia jasminoides, Protects against Lipopolysaccharide-Induced Acute Lung Injury in Mice
    Yang Xiaofeng
    Cai Qinren
    He Jingping
    Chu Xiao
    Wei Miaomiao
    Feng Xiangru
    Xie Xianxing
    Huo Meixia
    Liu Jing
    Wei Jingyuan
    Ci Xinxin
    Li Hongyu
    Deng Yanhong
    Jiang Lanxiang
    Deng Xuming
    PLANTA MEDICA, 2012, 78 (06) : 557 - 564
  • [43] Ficolin A derived from local macrophages and neutrophils protects against lipopolysaccharide-induced acute lung injury by activating complement
    Wu, Xu
    Yao, Duoduo
    Bao, Linlin
    Liu, Di
    Xu, Xiaoxue
    An, Yunqing
    Zhang, Xulong
    Cao, Bin
    IMMUNOLOGY AND CELL BIOLOGY, 2020, 98 (07): : 595 - 606
  • [44] BACTERICIDAL PERMEABILITY-INCREASING PROTEIN PROTECTS VASCULAR ENDOTHELIAL-CELLS FROM LIPOPOLYSACCHARIDE-INDUCED ACTIVATION AND INJURY
    ARDITI, M
    ZHOU, J
    HUANG, SH
    LUCKETT, PM
    MARRA, MN
    KIM, KS
    INFECTION AND IMMUNITY, 1994, 62 (09) : 3930 - 3936
  • [45] A novel myosin light chain kinase inhibitor, PIK, protects from lipopolysaccharide-induced acute lung injury.
    Mirzapoiazova, T.
    Sammani, S.
    Moreno, L.
    Dudek, S. M.
    Turner, J. R.
    Garcia, J. G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (02) : S357 - S357
  • [46] GSDMD inhibitor necrosulfonamide protects mice from galactosamine/lipopolysaccharide-induced acute liver failure via pyrotosis pathway
    Wu, Yi-Long
    Ou, Weijie
    Lin, Su
    Wang, Mingfang
    Huang, Jiaofeng
    Zhu, Yueyong
    JOURNAL OF HEPATOLOGY, 2020, 73 : S234 - S234
  • [47] Suppression of inducible nitric oxide synthase expression and amelioration of lipopolysaccharide-induced liver injury by polyphenolic compounds in Eucalyptus globulus leaf extract
    Sugimoto, Keiichiro
    Sakamoto, Sayaka
    Nakagawa, Kazuya
    Hayashi, Shuichi
    Harada, Naoki
    Yamaji, Ryoichi
    Nakano, Yoshihisa
    Inui, Hiroshi
    FOOD CHEMISTRY, 2011, 125 (02) : 442 - 446
  • [48] Enhancement by pyrazole of lipopolysaccharide-induced liver injury in mice: Role of cytochrome P450 2E1 and 2A5
    Lu, Yongke
    Cederbaum, Arthur I.
    HEPATOLOGY, 2006, 44 (01) : 263 - 274
  • [49] Protective Effect of the Total Triterpenes of Euscaphis konishii Hayata Pericarp on Bacillus Calmette-Guerin Plus Lipopolysaccharide-Induced Liver Injury
    Huang, Wei
    Ding, Hui
    Chen, Lu-yao
    Ni, Lin
    Ruan, Yi-fang
    Zou, Xiao-xing
    Ye, Min
    Zou, Shuang-quan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [50] ABIN-1 protects chondrocytes from lipopolysaccharide-induced inflammatory injury through the inactivation of NF-κB signalling
    Peng, Kan
    Li, Yanqi
    Lu, Chao
    Hu, Shouye
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2020, 47 (07) : 1212 - 1220